Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2012
11/01/2012WO2012147902A1 Antiarrhythmic drug, atrial fibrillation inhibitor, model of sustained atrial fibrillation and method for producing same, and method for screening atrial fibrillation inhibitor
11/01/2012WO2012147901A1 Composition for mitigating anticancer drug side effects
11/01/2012WO2012147853A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
11/01/2012WO2012147765A1 Benzimidazole derivative having npy y5 receptor antagonist action
11/01/2012WO2012147764A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012WO2012147470A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012WO2012146936A1 Pyrrolnitrin derivatives
11/01/2012WO2012146737A1 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease
11/01/2012WO2012146736A1 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
11/01/2012WO2012146724A2 Novel rock inhibitors
11/01/2012WO2012146642A1 Administration of iloprost as aerosol bolus
11/01/2012WO2012146318A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
11/01/2012WO2012146057A1 Curcuminoid injection solution and intravenous injection
11/01/2012WO2012109297A3 Atrial appendage occlusion and arrhythmia treatment
11/01/2012WO2012094437A3 Nicotinic receptor non-competitive antagonists
11/01/2012WO2012066234A9 Novel indolizine derivatives, and preparation and therapeutic use thereof
11/01/2012WO2012007539A9 Ip receptor agonist heterocyclic compounds
11/01/2012US20120277315 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/01/2012US20120277311 Lipoxin compounds and their use in treating cell proliferative disorders
11/01/2012US20120277309 Methods of controlling venous irritation associated with the treatment of a cardiac disorder
11/01/2012US20120277305 Fatty acid guanidine and salicylate guanidine derivatives and their uses
11/01/2012US20120277304 Sodium transhinone iia sulfonate hydrate and preparation method and use thereof
11/01/2012US20120277294 Functional food additives
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277282 Polynucleotides for use in medicine
11/01/2012US20120277280 Phenoxy-pyrrolidine derivative and its use and compositions
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277269 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
11/01/2012US20120277264 Antithrombotic agent
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277258 Chemical Compounds
11/01/2012US20120277256 Frequency modulated drug delivery (fmdd)
11/01/2012US20120277248 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277238 Pharmaceutical composition containing fused hetero-ring derivative
11/01/2012US20120277233 Pyridyl-Triazine Inhibitors of Hedgehog Signaling
11/01/2012US20120277227 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277226 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277220 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277215 Organic Compounds
11/01/2012US20120277205 Derivatives of n-[(1h-pyrazol-1-yl)aryl]-1h-indole or 1h-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
11/01/2012US20120277198 Polyhydroxylated bile acids for treatment of biliary disorders
11/01/2012US20120277196 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
11/01/2012US20120277189 Water-soluble benzoazepine compound and its pharmaceutical composition
11/01/2012US20120277188 Water-soluble benzoazepine compound and its pharmaceutical composition
11/01/2012US20120277173 Stabilized anthocyanin compositions
11/01/2012US20120277169 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277155 Therapy for kidney disease and/or heart failure
11/01/2012US20120277149 Pharmaceutical combinations for the treatment of metabolic disorders
11/01/2012US20120277144 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
11/01/2012US20120277143 IL4/IL13 Binding Repeat Proteins and Uses
11/01/2012US20120276228 Compositions and methods using pomegranate extracts
11/01/2012US20120276225 Phytoestrogenic nutraceutical composition from palm leaf extract
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276214 Infant nutrition with protease inhibitor
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276203 Collagen matrix for cell therapy
11/01/2012US20120276202 Collagen matrix for tissue engineering
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276152 Systems and methods of using zinc-chelator to treat myocardial infarction
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276130 Diagnostic and therapeutic methods for rheumatic heart disease based upon group a streptococcus markers
11/01/2012US20120276127 Treatment of retinal disorders with recombinant t cell receptor ligand (rtl)
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276111 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
11/01/2012US20120276091 Human Recombinant Monoclonal Antibody That Specifically Binds to VCAM-1 and Inhibits Adhesion and Transmigration Between Leukocytes and Endothelial Cells
11/01/2012US20120276089 Antibodies That Inhibit WNT Signaling And Methods Of Using The Same
11/01/2012US20120276083 Methods for inhibiting ocular angiogenesis
11/01/2012US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
11/01/2012US20120276062 Methods for treating ischemic tissue
11/01/2012US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
11/01/2012US20120276012 Method of Treatment and Screening Method
11/01/2012US20120276006 Contrast agents for myocardial perfusion imaging
11/01/2012US20120276000 Clec14a inhibitors
11/01/2012CA2834624A1 Il4/il13 binding repeat proteins and uses
11/01/2012CA2834516A1 Mfg-e8 and uses thereof
11/01/2012CA2834452A1 Derivatives of n- [( 1h - pyrazol - 1 - yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
11/01/2012CA2834429A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012CA2834387A1 Novel rock inhibitors
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2834215A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
11/01/2012CA2834063A1 Administration of iloprost as aerosol bolus
11/01/2012CA2834040A1 Intravascular delivery of nanoparticle compositions and uses thereof
11/01/2012CA2832693A1 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
10/2012
10/31/2012EP2518072A1 Imidazopyridazine compounds
10/31/2012EP2518067A1 Derivatives of N-[(1H-pyrazol-1-YL)aryl]-1H-indole or 1H- indazole-3-carboxamide and their therapeutic uses as P2Y12 antagonists
10/31/2012EP2518066A1 Novel anti-platelet agent
10/31/2012EP2518056A1 Seven-membered ring compound and pharmaceutical use therefor
10/31/2012EP2517711A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
10/31/2012EP2516433A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
10/31/2012EP2516417A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
10/31/2012EP2516405A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
10/31/2012EP2516393A1 Carboxamide compounds and their use as calpain inhibitors
10/31/2012EP2516011A1 Carrier composition
10/31/2012EP2515915A1 Compositions and methods related to mirna in diabetic conditions
10/31/2012EP2515900A1 Method of treating atrial fibrillation
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 1595